Lv1
80 积分 2022-03-27 加入
Comment on Frey et al A Real-World Pharmacovigilance Analysis of Lorlatinib-Associated Metabolic Effects Using the FDA Adverse Events Reporting System (FAERS) Database From 2013 to 2024
5小时前
求助中
The association of the Prognostic Nutritional Index (PNI) and Neutrophil-Lymphocyte Ratio (NLR) with cachexia in cancer patients
1个月前
已关闭
Compound Effect of Hypoalbuminemia and Obesity on Complications after Autologous Breast Reconstruction
1个月前
已关闭
Methodological considerations for recombinant human serum albumin clinical translation
1个月前
已完结
Mechanisms of cancer cachexia and targeted therapeutic strategies
1个月前
已完结
Effect of adjuvant EGFR-TKI therapy on the prognosis of pathological stage I invasive lung adenocarcinoma with sensitive EGFR mutations
1个月前
已完结
Current management of uncommon EGFR mutations in non-small cell lung cancer
2个月前
已完结
PT1.07.02 Neoadjuvant Ensartinib for ALK-Positive (ALK+) Non-Small Cell Lung Cancer (NSCLC): A Multicenter, Real-World Study
2个月前
已关闭
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
4个月前
已完结
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
4个月前
已完结
皖公网安备34019202002308
